Effectiveness of a home-based pulmonary rehabilitation maintenance programme: the Rehab2Life study protocol

Author:

Silva Liliana,Maricoto Tiago,Mota Ângela,Lemos Lara,Santos Mariana,Cunha Hélder,Azevedo Inês,Berger-Estilita Joana,Costa Patrício,Padilha José Miguel

Abstract

AbstractPulmonary rehabilitation (PR) is the bedrock of non-pharmacological treatment for people with COPD. Nonetheless, it is well described in the literature that unless the patient changes his behaviour, the benefits of PR programmes will decline in six to twelve months after finishing the programme. Therefore, maintenance programmes can address the problem of PR programmes’ effect loss over time.Community care units can provide multidisciplinary care in the current Portuguese primary health care context. These units have an interdisciplinary team that aims to develop competencies in COPD patients to self-manage the disease.This study aims to test the effectiveness of a 12-month home-based PR programme (Rehab2Life) compared to usual care through a single-blind randomised controlled trial with two parallel groups. The Rehab2Life programme includes two distinct phases. The first is an 8-week PR programme delivered to both groups, and the second is a PR maintenance programme delivered to the intervention group after the initial eight weeks. The control group receive the usual care and regular appointments. The primary outcome is functional capacity, and secondary outcomes are dyspnea, Health-Related Quality of Life (HRQoL), number of exacerbations, symptoms burden, anxiety and depression symptoms, and physical activity.We expect to observe that the home-based PR programme brings clinically relevant benefits to the participants at the end of the first eight weeks and that, at 12 months after the maintenance phase of the programme, benefits are less dissipated than in the control group. We expect to identify the characteristics of the patients who benefit the most from home-based programmes.The trial was registered on 7 April 2022 at ClinicalTrials.gov (NCT05315505).

Funder

Associação Portuguesa de Medicina Geral e Familiar

Publisher

Springer Science and Business Media LLC

Reference57 articles.

1. Machaqueiro S, Escoval A. A Reabilitação Respiratória para Doentes com Doença Pulmonar Obstrutiva Crónica. 2012.

2. Santos AC, Barreto C, Barata F, Froes F, Carvalho I, Pité I et al. 13o Relatório do Observatório Nacional das Doenças Respiratórias. Observatório nacional das doenças respiratórias [Internet]. 2018;45. https://www.ondr.pt/files/Relatorio_ONDR_2018.pdf.

3. Wadell K, Ferreira TJ, Arne M, Lisspers K, Stallberg B, Emtner M. Hospital-based pulmonary rehabilitation in patients with COPD in Sweden-A national survey. Respir Med. 2013;107(8):1195–200.

4. Holland AE, Cox NS, Houchen-wolloff L, Rochester CL, Garvey C, Zuwallack R et al. Am Thorac Soc Defining Mod Pulmonary Rehabilitation. 2021;18(5).

5. Spruit MA, Singh SJ, Garvey C, Zu Wallack R, Nici L, Rochester C et al. An official American thoracic society/European respiratory society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3